The federal report, created by the Department of Homeland Security and distributed to government agencies last week, found that the U.S. already is seeing shortages of more than 200 drugs and supplies due to international shutdowns.
The report is warning that another round of shutdowns could further strain the system in a way that many U.S.-based drugmakers would be “unable to quickly offset,” according to ABC.
“Chinese factories that produce raw ingredients for common antibiotics closed for weeks as of March, and India’s lockdown extended until the end of May,” the report said, according to ABC. “France, Germany, and China have also considered reimposing lockdown measures as COVID-19 cases have begun to reemerge.”
Read the full report here.
More articles on pharmacy:
Cheap steroid in shortage after being posited as potential COVID-19 treatment
Regeneron paid patient charity millions in kickbacks, lawsuit claims
Novartis pays DOJ, SEC $347M in kickback scheme settlement
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.